MICHELETTO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 1.473
EU - Europa 1.316
AS - Asia 1.049
SA - Sud America 162
AF - Africa 33
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.037
Nazione #
US - Stati Uniti d'America 1.446
SG - Singapore 432
GB - Regno Unito 350
CN - Cina 336
IT - Italia 325
BR - Brasile 145
HK - Hong Kong 130
DE - Germania 109
SE - Svezia 100
FR - Francia 98
RU - Federazione Russa 92
IE - Irlanda 76
FI - Finlandia 62
KR - Corea 34
PL - Polonia 30
JP - Giappone 26
CA - Canada 18
VN - Vietnam 18
IN - India 16
UA - Ucraina 16
ZA - Sudafrica 16
ID - Indonesia 14
BE - Belgio 12
NL - Olanda 12
AT - Austria 8
MX - Messico 8
MY - Malesia 8
TR - Turchia 7
TG - Togo 6
AZ - Azerbaigian 5
EC - Ecuador 5
ES - Italia 5
SA - Arabia Saudita 5
AR - Argentina 4
BD - Bangladesh 4
CZ - Repubblica Ceca 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
MA - Marocco 3
PE - Perù 3
TN - Tunisia 3
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
HU - Ungheria 2
LV - Lettonia 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GH - Ghana 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SN - Senegal 1
Totale 4.037
Città #
Southend 280
Chandler 226
Dallas 199
Singapore 186
Hong Kong 127
Jacksonville 125
Ashburn 104
Dublin 76
Redmond 69
Verona 66
Beijing 61
Ann Arbor 59
Houston 43
New York 42
Woodbridge 41
Milan 39
Munich 35
Lawrence 32
Princeton 32
Boardman 27
Jinan 25
Wilmington 25
Helsinki 22
Los Angeles 21
Rome 21
Sindelfingen 21
Tokyo 20
Changsha 18
The Dalles 18
Bologna 17
Columbus 17
São Paulo 17
Buffalo 16
Nanjing 16
Shenyang 16
Jakarta 13
Naples 13
Ningbo 13
Redondo Beach 13
Taizhou 13
Seattle 12
Zhengzhou 12
Tianjin 11
Turku 11
Brussels 10
Pretoria 10
Frankfurt am Main 9
Hebei 9
Falls Church 8
Haikou 8
Lanzhou 8
London 8
Toronto 8
Turin 8
Chicago 7
Kuala Lumpur 7
Taiyuan 7
Warsaw 7
Chennai 6
City of Westminster 6
Council Bluffs 6
Fuzhou 6
Guangzhou 6
Jiaxing 6
Kent 6
Lancaster 6
Lomé 6
Nuremberg 6
San Francisco 6
Auburn Hills 5
Baku 5
Brooklyn 5
Hangzhou 5
Johannesburg 5
Norwalk 5
Palermo 5
Redwood City 5
Rio de Janeiro 5
Salvador 5
Ancona 4
Atlanta 4
Boydton 4
Brescia 4
Brno 4
Delhi 4
Dongguan 4
Ho Chi Minh City 4
Lozzo Atestino 4
Manchester 4
Santa Clara 4
Seoul 4
Amsterdam 3
Bolzano 3
Catania 3
Charlotte 3
Curitiba 3
Denver 3
Dubai 3
Düsseldorf 3
Lappeenranta 3
Totale 2.575
Nome #
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management 310
Cost analysis of GER-induced asthma: a controlled study vs. atopic asthma of comparable severity. 275
A two-stage logistic Model Based on the Measurament of Pro-Infectious Cytokines in Bronchial Secretions for Assessing Bacterial, Viral and Non-Infectious Origin of COPD Exacerbation - Original Research 142
Assessment of COVID-19 progression on day 5 from symptoms onset 136
A MCh test pre-post esophageal acidification in detecting GER-related asthma. 127
Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease? 124
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 119
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 117
Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. 116
Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management. 110
Effect of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma 109
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 107
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 102
Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study. 101
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 101
PATTERN OF AIRWAY INFLAMMATION AND REMODELLING IN MILD PERSISTENT ATOPIC ASTHMA AND IN MILD PERSISTENT ASTHMA RELATED TO GASTROESOPHAGEAL REFLUX 99
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 99
Reference urinary LTE4 levels in normal individuals: a pilot study. 98
PIKO-1, an effective, handy device for the patient's personal PEFR and FEV1 electronic long-term monitoring. 98
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 95
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 90
Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma. 85
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 85
Omalizumab management beyond clinical trials: the added value of a network model 83
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 83
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 83
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 80
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 78
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 78
Nasal and Bronchial Tolerability of Rofecoxib in Patients with Aspirin induced Asthma 69
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times 68
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 68
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 65
Multidisciplinary management in type 2 inflammatory disease 63
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 58
Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol 50
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments 49
Profiling blood hypereosinophilia in patients on dupilumab treatment for respiratory conditions: a real-life snapshot 47
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 44
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence 43
Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy 39
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 35
CT radiomic models to distinguish COVID-19 pneumonia from other interstitial pneumonias 32
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 30
Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma 16
Totale 4.106
Categoria #
all - tutte 16.057
article - articoli 16.057
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021200 0 0 0 34 30 31 19 12 20 19 29 6
2021/2022366 52 113 12 22 8 9 5 22 13 8 25 77
2022/2023628 39 71 56 110 64 120 7 33 73 6 30 19
2023/2024497 27 38 47 47 45 78 26 36 12 28 77 36
2024/20251.158 78 59 48 158 50 48 83 82 185 78 101 188
2025/2026558 197 149 195 17 0 0 0 0 0 0 0 0
Totale 4.106